Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
Clinical trial NCT00422201 · TERMINATED
Trial details
- NCT number
- NCT00422201
- Sponsor
- HRA Pharma
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-15
- Primary completion
- 2012-04-04
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.